Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
Prosaposin:非裔美国人前列腺癌进展的新型生物标志物
基本信息
- 批准号:8147010
- 负责人:
- 金额:$ 18.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2011-07-02
- 项目状态:已结题
- 来源:
- 关键词:AffectAfrican AmericanAftercareAgeApoptoticBehaviorBenignBiologicalBiological AssayBiological MarkersCancer EtiologyCaucasiansCaucasoid RaceCell LineCell SurvivalCellsCessation of lifeCharacteristicsClinicalDataDevelopmentDiagnosisDiseaseDisease ProgressionEarly DiagnosisEnzyme-Linked Immunosorbent AssayExtracellular MatrixGlandGleason Grade for Prostate CancerHealth Services AccessibilityIn VitroIncidenceIndolentInvestigationLaboratoriesMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of prostateMetastatic Prostate CancerModelingMolecularNOD/SCID mouseNeoplasm MetastasisNude MiceOrganPC3 cell linePatientsPatternPeptide HydrolasesPhenotypePilot ProjectsPrimary NeoplasmPrognostic FactorProstateProteinsRNA InterferenceRadical ProstatectomyRisk FactorsSamplingScreening for Prostate CancerScreening procedureSerumSpecimenStagingStaining methodStainsTNMTestingTimeTissuesTumor MarkersUndifferentiatedXenograft procedurebasecancer cellcancer diagnosiscell motilityclinically significantfollow-upimplantationimprovedmRNA Expressionmenmigrationmortalitynoveloverexpressionprognosticprotein expressionpublic health relevanceracial differencesubcutaneoustissue resourcetumortumor growthtumor progressiontumor xenograft
项目摘要
DESCRIPTION (provided by applicant): Prostate cancer (PCa), the second leading cause of cancer-related death in US men, presents the greatest racial disparity of any malignant disease in African Americans, with a 1.6-1.9 times higher incidence rate and 2 - 3 times higher mortality rate than Caucasians. PCa in African Americans presents with more advanced clinical stages and aggressive tumors. PCa biomarkers are needed to improve early detection of clinically significant tumors and to distinguish indolent or slow growing tumors from more aggressive ones. In our search for tumor markers, we cloned prosaposin (PSAP) as a secreted protein and discovered its overexpression in metastatic PCa cells and tissues. Previously, we demonstrated that PSAP and/or its active molecular derivatives increase migration and invasion and up regulate matrix-degrading proteolytic enzymes expression in PCa cells. In Caucasians, serum-PSAP levels are increased in metastatic PCa when compared to primary PCa or normal prostate tissues. In addition, there was no difference in serum-PSAP levels between organ-confined and locally-invasive tumors. In contrast to Caucasians, our pilot study in African Americans shows that a) tissue expression of PSAP is significantly higher in undifferentiated tumors with Gleason grade 4/5 pattern than in the differentiated tumors with Gleason grade d 3 or benign glands (BPH) and b) serum-PSAP levels are higher in locally invasive (stage III/IV) tumors than in the organ-confined (stage I/II) tumors which positively correlates with disease progression. Based on these observations, we hypothesized that PSAP contributes to PCa progression and has the characteristics of a novel biomarker discriminating the aggressive tumors from non- aggressive ones in African American patients. To test our hypothesis, we propose the following Aims: 1) Define the clinical significance of serum-PSAP as a marker of PCa progression or aggressiveness in African Americans; 2) Determine the association between tissue expression of PSAP and clinical and histopathological predictors or prognosticators of PCa progression or aggressiveness in African Americans; and 3) Determine the association between PSAP and invasive and metastatic phenotypes in PSAP-over expressed or -silenced African American PCa cells. We will use immunohistochemical analysis and sandwich-ELISA assays to quantify PSAP expression levels in a large pool of tissue and serum samples and to determine their association with clinicohistopathological predictors or prognosticators of PCa aggressiveness and progression in African Americans. We will also test the effect of increased or decreased PSAP expression on tumor growth rate and spontaneous metastatic ability in subcutaneous and orthotopic tumor xenografts in African American- derived PCa cells. At the conclusion of this proposal, we will have defined the clinical and histopathological significance of PSAP as a biomarker of PCa progression and/or aggressiveness in African Americans that could be further utilized in clinical development.
PUBLIC HEALTH RELEVANCE: The incidences, mortality, and aggressiveness of prostate cancer (PCa) in African American (AA) men are higher than in Caucasians. To improve early detection of clinically significant tumors and to discriminate indolent or slow growing tumors from more aggressive ones, reliable prognostic factors or biomarkers are needed. An in-depth investigation of our preliminary discovery of a high expression of prosaposin (PSAP) levels in locally invasive and/or metastatic PCa cells, tissues, and serum samples from AA men would provide us with the clinical and histopathological values of this molecule as a biomarker for PCa screenings, diagnoses, or post-treatment follow up in AAs.
描述(由申请人提供):前列腺癌(PCa)是美国男性癌症相关死亡的第二大原因,在所有恶性疾病中,非裔美国人的种族差异最大,发病率比白种人高1.6-1.9倍,死亡率高2 - 3倍。非裔美国人的前列腺癌表现为更晚期的临床阶段和侵袭性肿瘤。需要PCa生物标志物来提高临床重要肿瘤的早期检测,并将惰性或生长缓慢的肿瘤与侵袭性肿瘤区分开来。在我们寻找肿瘤标志物的过程中,我们克隆了prosaposin (PSAP)作为一种分泌蛋白,并发现其在转移性前列腺癌细胞和组织中过表达。在此之前,我们已经证明PSAP和/或其活性分子衍生物增加了PCa细胞的迁移和侵袭,并上调了基质降解蛋白水解酶的表达。在白种人中,与原发性前列腺癌或正常前列腺组织相比,转移性前列腺癌的血清psap水平升高。此外,在器官局限性肿瘤和局部侵袭性肿瘤中,血清psap水平没有差异。与白种人相比,我们在非裔美国人中的初步研究表明:a)在Gleason分级4/5的未分化肿瘤中,PSAP的组织表达明显高于Gleason分级d3或良性腺体(BPH)的分化肿瘤;b)在局部侵袭性(III/IV期)肿瘤中,血清PSAP水平高于器官限制性(I/II期)肿瘤,这与疾病进展呈正相关。基于这些观察结果,我们假设PSAP有助于前列腺癌的进展,并且在非裔美国患者中具有区分侵袭性肿瘤和非侵袭性肿瘤的新生物标志物的特征。为了验证我们的假设,我们提出以下目标:1)定义血清psap作为非裔美国人前列腺癌进展或侵袭性标志的临床意义;2)确定PSAP的组织表达与非裔美国人前列腺癌进展或侵袭性的临床和组织病理学预测因子或预后因子之间的关系;3)确定PSAP过表达或沉默的非裔美国人PCa细胞中PSAP与侵袭性和转移性表型之间的关系。我们将使用免疫组织化学分析和夹心elisa法来量化大量组织和血清样本中PSAP的表达水平,并确定它们与非裔美国人前列腺癌侵袭性和进展的临床组织病理学预测因子或预后因子的关系。我们还将测试PSAP表达增加或减少对非洲裔美国人来源的PCa细胞皮下和原位肿瘤异种移植肿瘤生长速度和自发转移能力的影响。在本提案的结论中,我们将定义PSAP作为非裔美国人前列腺癌进展和/或侵袭性的生物标志物的临床和组织病理学意义,这可以进一步用于临床开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAHRIAR KOOCHEKPOUR其他文献
SHAHRIAR KOOCHEKPOUR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAHRIAR KOOCHEKPOUR', 18)}}的其他基金
Therapeutic Efficacy of Riluzole in Prostate Cancer
利鲁唑治疗前列腺癌的疗效
- 批准号:
8751365 - 财政年份:2014
- 资助金额:
$ 18.27万 - 项目类别:
Metabotropic Glutamate Receptor 1 in African American Prostate Cancer
非裔美国人前列腺癌中的代谢型谷氨酸受体 1
- 批准号:
8675361 - 财政年份:2014
- 资助金额:
$ 18.27万 - 项目类别:
Therapeutic Efficacy of Riluzole in Prostate Cancer
利鲁唑治疗前列腺癌的疗效
- 批准号:
8889227 - 财政年份:2014
- 资助金额:
$ 18.27万 - 项目类别:
Metabotropic Glutamate Receptor 1 in African American Prostate Cancer
非裔美国人前列腺癌中的代谢型谷氨酸受体 1
- 批准号:
8829801 - 财政年份:2014
- 资助金额:
$ 18.27万 - 项目类别:
PROSAPOSIN, A NOVEL INFLAMMATORY RESPONSE FACTOR FOR PROSTATE CANCER PROGRESSION
PROSAPOSIN,一种前列腺癌进展的新型炎症反应因子
- 批准号:
8360448 - 财政年份:2011
- 资助金额:
$ 18.27万 - 项目类别:
Prognostic value of AR mutation in primary African American prostate cancer
AR 突变在非裔美国人原发性前列腺癌中的预后价值
- 批准号:
8416144 - 财政年份:2010
- 资助金额:
$ 18.27万 - 项目类别:
Prognostic value of AR mutation in primary African American prostate cancer
AR 突变在非裔美国人原发性前列腺癌中的预后价值
- 批准号:
7989304 - 财政年份:2010
- 资助金额:
$ 18.27万 - 项目类别:
Significance of an novel germline AR mutation in black men with prostate cancer
患有前列腺癌的黑人男性中一种新的种系 AR 突变的意义
- 批准号:
8367933 - 财政年份:2010
- 资助金额:
$ 18.27万 - 项目类别:
Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
Prosaposin:非裔美国人前列腺癌进展的新型生物标志物
- 批准号:
8391445 - 财政年份:2010
- 资助金额:
$ 18.27万 - 项目类别:
Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
Prosaposin:非裔美国人前列腺癌进展的新型生物标志物
- 批准号:
8501024 - 财政年份:2010
- 资助金额:
$ 18.27万 - 项目类别:
相似海外基金
Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
- 批准号:
2306671 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
- 批准号:
10714464 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
- 批准号:
10723833 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
- 批准号:
10593806 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:
10811498 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
- 批准号:
2327055 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
- 批准号:
10782674 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
- 批准号:
10738855 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
- 批准号:
23K00376 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
基于种族的减压干预措施对有心血管代谢疾病风险的老年非洲裔美国女性的健康、炎症和 DNA 甲基化的影响
- 批准号:
10633624 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别: